Generate Biomedicines, Inc.
GENB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0002100782
In the last 90 days, Generate Biomedicines, Inc. insiders filed 0 open-market purchases and 1 sale; 86 institutions reported holding it in 13F filings for Q2 2026, worth $1.69B in total; ARK Invest is the only superinvestor holding it.
Q2 2026 vs. Q1 2026
How the institutions holding Generate Biomedicines, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 57 | 86 | +29 |
| Shares | 92.8M | 100.0M | +7.22M (+7.8%) |
| Value | $1.16B | $1.69B | +$530.4M (+45.8%) |
New holders (42)
Institutions that held Generate Biomedicines, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
Sold out (13)
Institutions that held Generate Biomedicines, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| Alyeska Investment Group, L.P. | 500,000 | $6.25M |
| ExodusPoint Capital Management, LP | 311,986 | $3.90M |
| Jane Street Group, LLC | 123,371 | $1.54M |
| Silverarc Capital Management, LLC | 100,000 | $1.25M |
| D. E. Shaw & Co., Inc. | 95,000 | $1.19M |
| Balyasny Asset Management LLC | 79,489 | $993.6K |
| HRT Financial LP | 58,762 | $734.0K |
| Qube Research & Technologies Ltd | 50,221 | $627.8K |
| Tudor Investment Corp Et Al | 23,833 | $297.9K |
| Y-Intercept (Hong Kong) Ltd | 18,362 | $229.5K |
| Hudson Bay Capital Management LP | 16,678 | $208.5K |
| Diametric Capital, LP | 10,497 | $131.2K |
| FNY Investment Advisers, LLC | 3,000 | $37.0K |